日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proteome-wide computational analyses reveal links between protein condensate formation and RNA biology

全蛋白质组计算分析揭示了蛋白质凝聚体形成与RNA生物学之间的联系

Maiti, Snigdha; Tripathi, Swarnendu; Baggett, David W; Phillips, Aaron H; Park, Cheon-Gil; Wang, Jina; Wahiduzzaman; Freyaldenhoven, William T; Kinger, Swati; Pioso, Brittany J; Bollinger, John C; Somjee, Ramiz; Lang, Benjamin; Babu, M Madan; Kriwacki, Richard W

Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioma

内在凋亡机制的综合分子和功能表征确定了胶质瘤的治疗弱点

Elizabeth G Fernandez, Wilson X Mai, Kai Song, Nicholas A Bayley, Jiyoon Kim, Henan Zhu, Marissa Pioso, Pauline Young, Cassidy L Andrasz, Dimitri Cadet, Linda M Liau, Gang Li, William H Yong, Fausto J Rodriguez, Scott J Dixon, Andrew J Souers, Jingyi Jessica Li, Thomas G Graeber, Timothy F Cloughesy

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.

AML获得性多药耐药是由复发性髓母细胞凋亡启动不足引起的

Olesinski Elyse A, Bhatia Karanpreet Singh, Wang Chuqi, Pioso Marissa S, Lin Xiao Xian, Mamdouh Ahmed M, Ng Shu Xuan, Sandhu Vedant, Jasdanwala Shaista Shabbir, Yilma Binyam, Bohl Stephan, Ryan Jeremy A, Malani Disha, Luskin Marlise R, Kallioniemi Olli, Porkka Kimmo, Adamia Sophia, Chng Wee Joo, Osato Motomi, Weinstock David M, Garcia Jacqueline S, Letai Anthony, Bhatt Shruti

DDDR-38. TRANSLATIONAL STEPS OF THE ANTITUMOR PEPTIDE TAT-CX43266-283 AS A TREATMENT FOR GLIOBLASTOMA: EGFR AS A TREATMENT RESPONSE BIOMARKER AND RESULTS OF COMBINATION THERAPY IN A PRECLINICAL RESECTION MODEL

DDDR-38. 抗肿瘤肽TAT-CX43266-283治疗胶质母细胞瘤的转化步骤:EGFR作为治疗反应生物标志物以及临床前切除模型中联合治疗的结果

Szczupak, Diego; LjungQvist Brinson, Lovisa; Kolarcik, Christi L; Nguyen, Thien; Lerman, Benjamin; Stoller, Schuyler; Müller, Timothy; Comfort, Lion; Leal-Ekman, Steven; Lyons, Samantha; Holman, Lynette; Junior, Calixito Hope Lucas; Banerjee, Anu; Reddy, Alyssa; Gupta, Nalin; Whipple, Nicholas; Gerber, Nicolas; Stuecklin, Ana; Areza, Esha; Marion, Rizo; Knowles, Truman; Solomon, David; Franson, Andrea; Koschmann, Carl; Partap, Sonia; Monje, Michelle; Prolo, Laura; Cheshier, Samuel; Antony, Reuben; Bhatia, Aashim; Foster, Jessica; LaRiviere, Michael; Maule, Laura; Carrion, Andrea Webster; Kline, Cassie; Bruningk, Sarah; Nazarian, Javad; Waszak, Sebastian; Mueller, Sabine; Cheng, Wen-Yu; Yang, Meng-Yin; Yeh, Chun-An; Yang, Yi-Chin; Shen, Chiung-Chyi; Hung, Huey-Shan; Li, Marissa; Pioso, Marissa; Breunig, Joshua; Grausam, Katie; Nathanson, David; Prins, Robert; Pioso, Marissa; Li, Marissa; Sanchez, Julio; Tamayo, Andrea; Grausam, Katie; Breunig, Joshua; Nathanson, David; Prins, Robert; Abdelfattah, Nourhan; Natarajan, Sivaraman; Tran, Han Nhat; Wong, Thomas; Maldonado, Jose; Borland, Hannah; McMinimy, Rachael; Chen, Shu-hsia; Camargo, Fernando; Olson, James; George, Joshy; Yun, Kyuson; Wang, Xin; Logun, Meghan; Sun, Yusha; Bagley, Stephen J; Li, Nannan; Desai, Arati; Zhang, Daniel Y; Nasrallah, MacLean P; Pai, Emily Ling-Lin; Oner, Bike Su; Plesa, Gabriela; Siegel, Donald; Binder, Zev A; Ming, Guo-li; Song, Hongjun; O’Rourke, Donald M; Álvarez-Vázquez, Andrea; Volovetz, Josephine; San-Segundo, Laura; Cerveró-García, Pilar; Flores-Hernández, Raquel; Ollauri-Ibáñez, Claudia; Segura-Collar, Berta; Hubert, Christopher G; Sánchez-Gómez, Pilar; Pollard, Steven M; Lathia, Justin D; Tabernero, Arantxa

Defining the condensate landscape of fusion oncoproteins

定义融合癌蛋白的凝聚态图谱

Tripathi, Swarnendu; Shirnekhi, Hazheen K; Gorman, Scott D; Chandra, Bappaditya; Baggett, David W; Park, Cheon-Gil; Somjee, Ramiz; Lang, Benjamin; Hosseini, Seyed Mohammad Hadi; Pioso, Brittany J; Li, Yongsheng; Iacobucci, Ilaria; Gao, Qingsong; Edmonson, Michael N; Rice, Stephen V; Zhou, Xin; Bollinger, John; Mitrea, Diana M; White, Michael R; McGrail, Daniel J; Jarosz, Daniel F; Yi, S Stephen; Babu, M Madan; Mullighan, Charles G; Zhang, Jinghui; Sahni, Nidhi; Kriwacki, Richard W

Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation

相分离介导 NUP98 融合癌蛋白白血病转化

Bappaditya Chandra #, Nicole L Michmerhuizen #, Hazheen K Shirnekhi #, Swarnendu Tripathi #, Brittany J Pioso, David W Baggett, Diana M Mitrea, Ilaria Iacobucci, Michael R White, Jingjing Chen, Cheon-Gil Park, Huiyun Wu, Stanley Pounds, Anna Medyukhina, Khaled Khairy, Qingsong Gao, Chunxu Qu, Sherif

Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy

抑制 IL-17A 可预防甲状腺免疫相关不良事件,同时保持检查点抑制剂的抗肿瘤功效

Melissa G Lechner, Mandy I Cheng, Anushi Y Patel, Aline T Hoang, Natalie Yakobian, Michael Astourian, Marissa S Pioso, Eduardo D Rodriguez, Ethan C McCarthy, Willy Hugo, Trevor E Angell, Alexandra Drakaki, Antoni Ribas, Maureen A Su

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia

线粒体凋亡启动减少导致急性髓系白血病对BH3模拟物产生耐药性

Shruti Bhatt ,Marissa S Pioso ,Elyse Anne Olesinski ,Binyam Yilma ,Jeremy A Ryan ,Thelma Mashaka ,Buon Leutz ,Sophia Adamia ,Haoling Zhu ,Yanan Kuang ,Abhishek Mogili ,Abner Louissaint Jr ,Stephan R Bohl ,Annette S Kim ,Anita K Mehta ,Sneha Sanghavi ,Youzhen Wang ,Erick Morris ,Ensar Halilovic ,Cloud P Paweletz ,David M Weinstock ,Jacqueline S Garcia ,Anthony Letai

High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors

高通量动态 BH3 分析可以快速准确地预测实体肿瘤的有效治疗方法

Patrick D Bhola, Eman Ahmed, Jennifer L Guerriero, Ewa Sicinska, Emily Su, Elizaveta Lavrova, Jing Ni, Otari Chipashvili, Timothy Hagan, Marissa S Pioso, Kelley McQueeney, Kimmie Ng, Andrew J Aguirre, James M Cleary, David Cocozziello, Alaba Sotayo, Jeremy Ryan, Jean J Zhao, Anthony Letai

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML

高通量筛选表明吉西他滨和 JAK 抑制剂可能有助于治疗儿童 AML

Christina D Drenberg, Anang Shelat, Jinjun Dang, Anitria Cotton, Shelley J Orwick, Mengyu Li, Jae Yoon Jeon, Qiang Fu, Daelynn R Buelow, Marissa Pioso, Shuiying Hu, Hiroto Inaba, Raul C Ribeiro, Jeffrey E Rubnitz, Tanja A Gruber, R Kiplin Guy, Sharyn D Baker